|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| CURRENT ASSETS: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Accounts receivable (net of allowance for credit losses of $3,212 and $2,816 at June 30, 2024 and December 31, 2023, respectively) | ||||||||||||
| Insurance receivable | ||||||||||||
| Prepaid expenses | ||||||||||||
| Operating leases right-of-use asset | ||||||||||||
| Other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Goodwill | ||||||||||||
| Intangible assets, net | ||||||||||||
| Deferred tax assets | ||||||||||||
| Operating leases right-of-use asset | ||||||||||||
| Other noncurrent assets, net | ||||||||||||
| TOTAL ASSETS | ||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||
| CURRENT LIABILITIES: | ||||||||||||
| Accounts payable | ||||||||||||
| Litigation settlement obligation | ||||||||||||
| Accrued expenses | ||||||||||||
| Current portion of long-term debt | ||||||||||||
| Operating leases liability, current portion | ||||||||||||
| Income tax payable, current portion | ||||||||||||
| Other current liabilities | ||||||||||||
| Total current liabilities | ||||||||||||
| Long-term debt, net | ||||||||||||
| Deferred tax liabilities | ||||||||||||
| Long-term operating leases liability, net of current portion | ||||||||||||
| Other liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||
| Preferred stock ($0.01 par value; 100,000,000 shares authorized; no shares issued or outstanding) | ||||||||||||
| Common stock ($0.01 par value; 1,000,000,000 shares authorized; 105,429,219 shares issued and 97,901,748 shares outstanding at June 30, 2024; 99,966,158 shares issued and 93,194,403 shares outstanding at December 31, 2023) | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Common stock held in treasury (7,527,471 and 6,771,755 shares at June 30, 2024 and December 31, 2023, respectively) | ||||||||||||
| Accumulated deficit | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Total stockholders’ equity | ||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
